CUSIP: 62921N105
Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
39,267,121
-
Share change
-
+5,679,328
-
Total reported value
-
$1,141,407,737
-
Price per share
-
$29.07
-
Number of holders
-
102
-
Value change
-
+$164,908,439
-
Number of buys
-
61
-
Number of sells
-
25
Quarterly Holders Quick Answers
What is CUSIP 62921N105?
CUSIP 62921N105 identifies NGM - NGM BIOPHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Institutional Holders of NGM BIOPHARMACEUTICALS INC - COM (NGM) as of Q1 2021
As of 31 Mar 2021,
NGM BIOPHARMACEUTICALS INC - COM (NGM) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,267,121 shares.
The largest 10 holders included
The Column Group LLC, BlackRock Inc., Redmile Group, LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., Greenspring Associates, LLC, Euclidean Capital LLC, Ponoi II Management, LLC, Ponoi Management, LLC, and Aquilo Capital Management, LLC.
This page lists
102
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.